Latin America Over The Counter (OTC) Drugs Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

Date : Mar 2018

Formats :
Report Code : PMR83649631

Category : Pharmaceutical and Healthcare
No Of Pages :
Latin America Over The Counter OTC Drugs Market


Overthecounter OTC drugs Market, also known as the nonprescription drugs that can be bought without a prescription. Overthecounter drugs are safe and effective when the consumer follows the directions on the label or as provided by a physician. Overthecounter OTC drugs are primarily used to treat conditions that do not require direct consultation of a doctor. Overthecounter drugs provide affordable treatment and also help to decrease the workload of physicians. Overthecounter drugs are easily available in pharmacies. Even though these products are considered as overthecounter because these are not directly kept on pharmacy counters and must be dispensed by a pharmacist after confirming age, identity, and patient knowledge regarding usage of the product.



Latin America OTC drugs market is growing at a significant CAGR due to rise in the population. Increase in the adoption of western lifestyles, promotion and marketing initiatives for overthecounter products, the rise in the healthcare expenditure, and an increase in the geriatric population expected to fuel the Latin America Over The Counter Drugs Market over the forecast period. Furthermore, rise in demand for selfmedication with nonprescription drugs, changes in cultural attitudes regarding selfmedications required for minor health problems, convenience in the direct purchase, savings enabled by the use of overthecounter drugs, and developments and innovations in drugs products expected to fuel the LatinAmerica overthecounter drugs market. However, competition between the existing market players, more possibilities of substance addiction and abuse, severity and complications involved in the taking of wrong medications due to misdiagnosis and lack of awareness among the rural population in developing and underdeveloped countries might hinder the Latin America overthecounter drugs market over the forecast period.



The Latin America Over The Counter Drugs Market is segmented on the basis of product type, formulation type, and distribution channel



Based on product type, Latin America Over The Counter Drugs Market has been segmented into the following:

Pain Products
Cough, Cold and Flu Products
Vitamins and Minerals
Gastrointestinal Products
Ophthalmic Products
Sleep Aid Products
Weight Loss/Diet Products
Others


Based on formulation type, Latin America Over The Counter Drugs Market has been segmented into the following:

Tablets
Liquids
Ointments
Sprays
Others


Based on distribution channel, Latin America Over The Counter Drugs Market has been segmented into the following:

Pharmacies
Supermarkets/Hypermarkets
Convenience stores
Online drugstores
Others


The Latin America Over The Counter Drugs Market is in the flourishing stage with several local and international players actively engaged in the launch of new products to increase their market share in the Latin America overthecounter drugs market. Some of the key strategies followed by various pharmaceutical companies include acquisitions and mergers, collaborations, and technological innovations for overthecounter drugs. For instance, in February 2013, Reckitt Benckiser, the manufacturer of Nurofen painkillers, paid to BristolMyers Squibb about US$ 482 Mn to license a portfolio of Latin American overthecounter healthcare products. Moreover, in December 2017, Perrigo Company plc received FDA approval for Nicorette over the product and the company plans to launch the product in various countries including Latin America.



Geographically, Latin America Over The Counter Drugs Market segmented into the following countries such as Brazil, Mexico, Chile, Argentina, Venezuela and Rest of Latin America as these are the largest pharmaceutical markets in the region. Brazil holds the largest share, which is attributed to highest population among all Latin American countries, increase in awareness regarding the overthecounter drugs. OTC drugs such as analgesics and contraceptives are commonly used in the Brazil. In Argentina, it is very common that a citizen can buy antibiotics without a prescription. Increase in population, advertising and marketing regarding the overthecounter drugs, and ease of availability of overthecounter drugs expected to fuel the Latin America overthecounter drugs market over the forecast period.



Some of the players in Latin America Over The Counter Drugs Market are Novartis AG Switzerland, Pfizer, Inc. U.S., Valeant Canada, Perrigo Company plc. U.S., SanofiAventis France, GlaxoSmithKline plc. U.K., Johnson & Johnson Services, Inc. U.S., Bayer AG Germany, Takeda Pharmaceuticals company Ltd. Japan, Teva Pharmaceutical Industries Ltd. Israel, BristolMyers Squibb U.S., and Reckitt Benckiser Group plc U.K. to name a few.



In September 2018, Isodiol International Inc. planned to launch OTC products in the Latin America region


In May 2014, Bayer acquired the consumer care business of Merck & Co., Inc., in Latin America and North America regions
1. Executive Summary
2. Latin America Over The Counter OTC Market Introduction
2.1. Latin America Over The Counter OTC Market – Taxonomy
2.2. Latin America Over The Counter OTC Market –Definitions
2.2.1. Product Type
2.2.2. Formulation Type
2.2.3. Distribution Channel
3. Latin America Over The Counter OTC Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Latin America Over The Counter OTC Market Dynamics – Factors Impact Analysis
3.6. Latin America Over The Counter OTC Market – Regulations
3.7. Latin America Over The Counter OTC Market – Product Innovations
4. Latin America Over The Counter OTC Market Analysis, 2013 2017 and Forecast, 2018 – 2024
4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
4.2. YearoverYear YoY Growth Analysis %
4.3. Market Oppurtunity Analysis
5. Latin America Over The Counter OTC Market, By Product, 2013 2017 and Forecast, 2018 2024
5.1. Pain Products
5.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
5.1.2. YearoverYear YoY Growth Analysis % and Market Share Analysis
5.1.3. Market Opportunity Analysis
5.2. Cough, Cold and Flu Products
5.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
5.2.2. YearoverYear YoY Growth Analysis % and Market Share Analysis
5.2.3. Market Opportunity Analysis
5.3. Vitamins and Minerals
5.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
5.3.2. YearoverYear YoY Growth Analysis % and Market Share Analysis
5.3.3. Market Opportunity Analysis
5.4. Gastrointestinal Products
5.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
5.4.2. YearoverYear YoY Growth Analysis % and Market Share Analysis
5.4.3. Market Opportunity Analysis
5.5. Ophthalmic Products
5.5.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
5.5.2. YearoverYear YoY Growth Analysis % and Market Share Analysis
5.5.3. Market Opportunity Analysis
5.6. Sleep Aid Products
5.6.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
5.6.2. YearoverYear YoY Growth Analysis % and Market Share Analysis
5.6.3. Market Opportunity Analysis
5.7. Weight Loss/Diet Products
5.7.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
5.7.2. YearoverYear YoY Growth Analysis % and Market Share Analysis
5.7.3. Market Opportunity Analysis
5.8. Others
5.8.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
5.8.2. YearoverYear YoY Growth Analysis % and Market Share Analysis
5.8.3. Market Opportunity Analysis
6. Latin America Over The Counter OTC Market Forecast, By Formulation Type, 2013 2017 and Forecast, 2018 2024
6.1. Tablets
6.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
6.1.2. YearoverYear YoY Growth Analysis % and Market Share Analysis
6.1.3. Market Opportunity Analysis
6.2. Liquids
6.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
6.2.2. YearoverYear YoY Growth Analysis % and Market Share Analysis
6.2.3. Market Opportunity Analysis
6.3. Ointments
6.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
6.3.2. YearoverYear YoY Growth Analysis % and Market Share Analysis
6.3.3. Market Opportunity Analysis
6.4. Sprays
6.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
6.4.2. YearoverYear YoY Growth Analysis % and Market Share Analysis
6.4.3. Market Opportunity Analysis
6.5. Others
6.5.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
6.5.2. YearoverYear YoY Growth Analysis % and Market Share Analysis
6.5.3. Market Opportunity Analysis
7. Latin America Over The Counter OTC Market Forecast, By Distribution Channel, 2013 2017 and Forecast, 2018 2024
7.1. Pharmacies
7.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
7.1.2. YearoverYear YoY Growth Analysis % and Market Share Analysis
7.1.3. Market Opportunity Analysis
7.2. Supermarkets/Hypermarkets
7.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
7.2.2. YearoverYear YoY Growth Analysis % and Market Share Analysis
7.2.3. Market Opportunity Analysis
7.3. Convenience stores
7.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
7.3.2. YearoverYear YoY Growth Analysis % and Market Share Analysis
7.3.3. Market Opportunity Analysis
7.4. Online drugstores
7.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
7.4.2. YearoverYear YoY Growth Analysis % and Market Share Analysis
7.4.3. Market Opportunity Analysis
7.5. Others
7.5.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
7.5.2. YearoverYear YoY Growth Analysis % and Market Share Analysis
7.5.3. Market Opportunity Analysis
8. Argentina Over The Counter OTC Market Analysis, 2013 2017 and Forecast, 2018 2024
8.1. Product Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth %, and Market Share %
8.1.1. Pain Products
8.1.2. Cough, Cold and Flu Products
8.1.3. Vitamins and Minerals
8.1.4. Gastrointestinal Products
8.1.5. Ophthalmic Products
8.1.6. Sleep Aid Products
8.1.7. Weight Loss/Diet Products
8.1.8. Others
8.2. Formulation Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth % and Market Share %
8.2.1. Tablets
8.2.2. Liquids
8.2.3. Ointments
8.2.4. Sprays
8.2.5. Others
8.3. Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth % and Market Share %
8.3.1. Pharmacies
8.3.2. Supermarkets/Hypermarkets
8.3.3. Convenience stores
8.3.4. Online drugstores
8.3.5. Others
8.4. Argentina Over The Counter OTC Market Opportunity Analysis Index, By Product, Formulation Type, Distribution Channel and Country, 2018 – 2024
8.5. Argentina Over The Counter OTC Market Dynamics – Trends
9. Brazil Over The Counter OTC Market Analysis, 2013 2017 and Forecast, 2018 2024
9.1. Product Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth %, and Market Share %
9.1.1. Pain Products
9.1.2. Cough, Cold and Flu Products
9.1.3. Vitamins and Minerals
9.1.4. Gastrointestinal Products
9.1.5. Ophthalmic Products
9.1.6. Sleep Aid Products
9.1.7. Weight Loss/Diet Products
9.1.8. Others
9.2. Formulation Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth % and Market Share %
9.2.1. Tablets
9.2.2. Liquids
9.2.3. Ointments
9.2.4. Sprays
9.2.5. Others
9.3. Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth % and Market Share %
9.3.1. Pharmacies
9.3.2. Supermarkets/Hypermarkets
9.3.3. Convenience stores
9.3.4. Online drugstores
9.3.5. Others
9.4. Brazil Over The Counter OTC Market Opportunity Analysis Index, By Product, Formulation Type, Distribution Channel and Country, 2018 – 2024
9.5. 9.4. Brazil Over The Counter OTC Market Dynamics – Trends
10. Mexico Over The Counter OTC Market Analysis, 2013 2017 and Forecast, 2018 2024
10.1. Product Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth %, and Market Share %
10.1.1. Pain Products
10.1.2. Cough, Cold and Flu Products
10.1.3. Vitamins and Minerals
10.1.4. Gastrointestinal Products
10.1.5. Ophthalmic Products
10.1.6. Sleep Aid Products
10.1.7. Weight Loss/Diet Products
10.1.8. Others
10.2. Formulation Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth % and Market Share %
10.2.1. Tablets
10.2.2. Liquids
10.2.3. Ointments
10.2.4. Sprays
10.2.5. Others
10.3. Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth % and Market Share %
10.3.1. Pharmacies
10.3.2. Supermarkets/Hypermarkets
10.3.3. Convenience stores
10.3.4. Online drugstores
10.3.5. Others
10.4. Mexico Over The Counter OTC Market Opportunity Analysis Index, By Product, Formulation Type, Distribution Channel and Country, 2018 – 2024
10.5. 9.4. Mexico Over The Counter OTC Market Dynamics – Trends
11. Rest of Latin America Over The Counter OTC Market Analysis, 2013 2017 and Forecast, 2018 2024
11.1. Product Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth %, and Market Share %
11.1.1. Pain Products
11.1.2. Cough, Cold and Flu Products
11.1.3. Vitamins and Minerals
11.1.4. Gastrointestinal Products
11.1.5. Ophthalmic Products
11.1.6. Sleep Aid Products
11.1.7. Weight Loss/Diet Products
11.1.8. Others
11.2. Formulation Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth % and Market Share %
11.2.1. Tablets
11.2.2. Liquids
11.2.3. Ointments
11.2.4. Sprays
11.2.5. Others
11.3. Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth % and Market Share %
11.3.1. Pharmacies
11.3.2. Supermarkets/Hypermarkets
11.3.3. Convenience stores
11.3.4. Online drugstores
11.3.5. Others
11.4. Rest of Latin America Over The Counter OTC Market Opportunity Analysis Index, By Product, Formulation Type, Distribution Channel and Country, 2018 – 2024
11.5. 9.4. Rest of Latin America Over The Counter OTC Market Dynamics – Trends
12. Competition Landscape
12.1. Strategic Dashboard of Top Market Players
12.2. Company Profiles Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis
12.2.1. Novartis AG Switzerland
12.2.2. Pfizer, Inc. U.S.
12.2.3. Valeant Canada
12.2.4. Perrigo Company plc. U.S.
12.2.5. Sanofi France
12.2.6. GlaxoSmithKline plc. U.K.
12.2.7. Johnson & Johnson Services, Inc. U.S.
12.2.8. Bayer AG Germany
12.2.9. Takeda Pharmaceuticals company Ltd. Japan
12.2.10. Teva Pharmaceutical Industries Ltd. Israel
12.2.11. BristolMyers Squibb U.S.
12.2.12. Reckitt Benckiser Group plc U.K.
13. Research Methodology
14. Key Assumptions and Acronyms
  Purchase Options for Report

Need More information

Call us :
USA : +1 7162260907
UK : +44 7441952057
....
sales@planetmarketreports.com

Why to PMR

PMR Market Research

Our syndicated research reports cover 50+ industry sectors offering you product and country wise breakup of the market along with niche data and insights that will help you make informed business decision. Our research is focused on the key segments of an industry that possess opportunities of growth.

  • Industrial ...
  • Business ....
  • Consumer ....
  • Peer ....